Luis Fernando López-Cortés (Luis López-Cortés, Luis F Lopez-Cortes)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Microbiology spectrum

Viruses

Journal of clinical medicine

PloS one

Instituto de Biomedicina de Sevilla

Universidad de Sevilla (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto de Biomedicina de Sevilla Jul 01 2010

Spain

Head of research group :: Infectious diseases

Hospital Universitario Virgen del Rocío Aug 01 1992

Spain

Senior consultant :: Infectious diseases

Education History

Universidad de Sevilla Mar 22 1986

Spain

PHD :: Medicina

Publications

Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis Fernando López-Cortés, Alicia Gutiérrez, Jesús Santos, Francisco Téllez, Mohamed Omar, Sergio Ferra, Elisa Fernández, Rosario Javier, Coral García-Vallecillos, Juan Pasquau
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain. Viruses 16 (2) (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum 12 (8) (2024)
Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis Fernando López-Cortés, Alicia Gutiérrez, Jesús Santos, Francisco Téllez, Mohamed Omar, Sergio Ferra, Elisa Fernández, Rosario Javier, Coral García-Vallecillos, Juan Pasquau
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain. Viruses 16 (2) (2024)
Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis Fernando López-Cortés, Alicia Gutiérrez, Jesús Santos, Francisco Téllez, Mohamed Omar, Sergio Ferra, Elisa Fernández, Rosario Javier, Coral García-Vallecillos, Juan Pasquau
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain. Viruses 16 (2) (2024)
Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis Fernando López-Cortés, Alicia Gutiérrez, Jesús Santos, Francisco Téllez, Mohamed Omar, Sergio Ferra, Elisa Fernández, Rosario Javier, Coral García-Vallecillos, Juan Pasquau
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain. Viruses 16 (2) (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum 12 (8) (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum (2024)
Abraham Saborido-Alconchel, Ana Serna-Gallego, Luis Eduardo Lopez-Cortes, María Trujillo-Rodriguez, Juan Manuel Praena-Fernandez, Montserrat Dominguez-Macias, Carmen Lozano, Esperanza Muñoz-Muela, Nuria Espinosa, Cristina Roca-Oporto, Cesar Sotomayor, Marta Herrero, Alicia Gutiérrez-Valencia, Luis Fernando López-Cortés
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV. The Journal of antimicrobial chemotherapy (2023)
Laura Herrera-Hidalgo, Jose Manuel Lomas-Cabezas, Luis Eduardo Lopez-Cortes, Rafael Luque-Márquez, Luis Fernando López-Cortés, Francisco J Martínez-Marcos, Javier De La Torre, Antonio José Plata Ciézar, Carmen Hidalgo-Tenorio, Maria Victoria García-López, David Vinuesa, Alicia Gutiérrez-Valencia, Maria Victoria Gil-Navarro, Arístides De Alarcón
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT. Journal of clinical medicine 11 (1) (2021)
Yusnelkis Milanés-Guisado, Alicia Gutiérrez-Valencia, María Trujillo-Rodríguez, Nuria Espinosa, Pompeyo Viciana, Luis Fernando López-Cortés
Absolute CD4+ T cell count overstate immune recovery assessed by CD4+/CD8+ ratio in HIV-infected patients on treatment. PloS one 13 (10) (2018)

Luis Fernando López-Cortés.css-eqlu8i{font-size:small;padding-left:4px;} (Luis López-Cortés, Luis F Lopez-Cortes)

Publication Activity (10 Years)

Top Topics

Top Venues

Luis Fernando López-Cortés (Luis López-Cortés, Luis F Lopez-Cortes)